Clinical Trials in Tennessee

Showing 6641-6660 of 15,329 trials

Adaptation of Ca-HELP Intervention in Rural Geriatric Cancer Patient Population

NCT04262232

The Cancer Health Empowerment for Living without Pain (Ca-HELP) is an evidence-based communication tool that empowers and engages patients to communicate effectively with their physicians about pain. The Ca-HELP intervention is rooted in social-cognitive theory which posits that behavior change and maintenance depends largely on individuals' ability and self-efficacy to execute a specific behavior. Ca-HELP coaches patients to ask questions, make requests, and signal distress to their physicians in order to achieve improved pain control. Previous research indicates significant improvement among cancer patients in their self-efficacy to communicate about their pain to their oncologists and reductions in pain misconceptions and pain-related impairment. Although a promising tool among geriatric cancer patients, Ca-HELP is not currently designed for optimal dissemination in rural settings.

Pain

Weill Medical College of Cornell University30 participantsStarted May 2021

Columbia, Tennessee, United States

COMPLETEDPhase 229 miles

A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

NCT02399813

This is a single arm Phase 2 study. Stage 1 and 2 of the study are monotherapy evaluations of ADXS11-001 in 31 and 24 participants, respectively with persistent/recurrent, loco-regional or metastatic squamous cell carcinoma (SCCA) of the anorectal canal that have received at least 1 regimen for the treatment of advanced disease.

Anal CancerRectal Cancer

Advaxis, Inc.36 participantsStarted Jun 2016

Duarte, California, United States • New Haven, Connecticut, United States • Indianapolis, Indiana, United States +7 more locations

Adaptation of Ca-HELP Intervention in Rural Geriatric Cancer Patient Population

A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

Find Trials by Condition in Tennessee

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

First in Human Study of M4344 in Participants With Advanced Solid Tumors

A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis

OPTIMIZE IDE for the Treatment of ACS

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

Assessment of Acute Disease to Reduce Imaging Costs

A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

Bioavailability of EPA + DHA in a SMEDS Formulation

Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)

Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL

FREEDOM COVID-19 Anticoagulation Strategy

The TREFOIL Concept 5 Year Clinical Investigation